long term side effects glp 1 Exploring the of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Best GLP-1 for Weight Loss:
Description
Glucagon-like peptide-1 (GLP-1) is an endogenous neurotransmitter that plays a role in glucose homeostasis through insulin secretion and enhancing insulin sensitivity [10]

The cardiovascular benefits observed with these medications include: Reduction in non-fatal myocardial infarction and stroke Decreased cardiovascular mortality in high-risk populations (demonstrated with liraglutide) Improvements in blood pressure and lipid profiles Weight reduction , which independently lowers cardiovascular risk It is important to distinguish between arterial thrombotic events (such as heart attacks and strokes, which some GLP-1 agonists help prevent) and venous thromboembolism (DVT and PE)

Those who had nausea or vomiting while using Liraglutide 3.0 mg lost 9.2 kg per year, compared to 6.3 kg for those who did not
Upon receptor binding, both of these hormones stimulate adenylate cyclase, resulting in the enhancement of cyclic adenosine monophosphate (cAMP) in -cells

10.1080/15548627.2020.1731270 [DOI] [PMC free article] [PubMed] [Google Scholar] Jastreboff A
The anti-inflammatory properties of GLP-1 agonists additionally contribute to their cardiovascular benefits